VA
Vaishali Pharma Limited
VAISHALI.NS · NSE
₹8.16 -1.45% (-₹0.12)
1M -1.08%
Market Cap ₹891.8M
P/E Ratio 20.84x
Div. Yield -
ROE 6.37%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
56 /100
Fair EV/EBITDA 21.03x
P/S 0.83x
P/B 1.29x
Growth
58 /100
Stable Rev. growth 6.05%
FCF growth 37.25%
Book val. growth 23.76%
Profitability
13 /100
Weak Net margin 3.97%
Op. margin 3.37%
FCF margin 0.00%
Quality
30 /100
Poor ROE 6.37%
ROA 3.47%
Asset turnover 0.87x
Debt
63 /100
Moderate Current ratio 2.34x
Int. coverage 2.45x
Net debt/EBITDA 3.44x
Stability
36 /100
Moderate Rev. volatility 28.31%
EPS volatility 1,753.02%
Profitable years 6
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VAISHALI.NS
Online
Sector
Healthcare
Industry
Medical - Pharmaceuticals
CEO
Hemanth Damodar Pathak
Employees
27
Headquarters
Mumbai